Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

MTFB

Motif Bio (MTFB)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
DataOraFonteTitoloSimboloCompagnia
21/12/201714:00RNS Non-RegulatoryMotif Bio PLC REVIVE-1 additional results publishedLSE:MTFBMotif Bio Plc
14/12/201708:01RNS Non-RegulatoryMotif Bio PLC Filing of SEC Form F-3LSE:MTFBMotif Bio Plc
28/11/201719:24UK RegulatoryMotif Bio PLC Holding(s) in CompanyLSE:MTFBMotif Bio Plc
17/11/201711:08Alliance NewsAlliance NewsMotif Bio Gets GBP59,000 From Warrant Exercise (ALLISS)LSE:MTFBMotif Bio Plc
17/11/201708:20Alliance NewsAlliance News*Motif Bio To Issue 183,031 Shares For GBP58,935 From Warrants Exercise (ALLISS)LSE:MTFBMotif Bio Plc
17/11/201708:01UK RegulatoryMotif Bio PLC Exercise of WarrantsLSE:MTFBMotif Bio Plc
15/11/201710:46Alliance NewsAlliance NewsMotif Bio Secures USD20 Million Debt Facility From Hercules CapitalLSE:MTFBMotif Bio Plc
15/11/201708:00UK RegulatoryMotif Bio PLC Secures up to US$20 million debt financingLSE:MTFBMotif Bio Plc
06/11/201714:07Alliance NewsAlliance NewsBank Of America Raises Stake In Biopharmaceutical Firm Motif Bio (ALLISS)LSE:MTFBMotif Bio Plc
06/10/201715:19Alliance NewsAlliance NewsMerrill Lynch Ups Motif Bio Stake Following Iclaprim Results (ALLISS)LSE:MTFBMotif Bio Plc
06/10/201710:54Alliance NewsAlliance NewsMotif Bio Receives Positive Pre-Clinical Data For Iclaprim DrugLSE:MTFBMotif Bio Plc
06/10/201708:00RNS Non-RegulatoryMotif Bio PLC New Pre-Clinical Data for Iclaprim at IDWeek 2017LSE:MTFBMotif Bio Plc
04/10/201709:31Alliance NewsAlliance NewsMotif Bio Shares Jump On Positive Late-Stage Iclaprim Study ResultsLSE:MTFBMotif Bio Plc
04/10/201708:00UK RegulatoryMotif Bio PLC Positive Topline Results in Phase Three StudyLSE:MTFBMotif Bio Plc
29/09/201713:22Alliance NewsAlliance NewsMotif Bio On Track For Strategic Goals As Interim Loss WidensLSE:MTFBMotif Bio Plc
29/09/201708:02UK RegulatoryMotif Bio PLC Half-year ReportLSE:MTFBMotif Bio Plc
25/09/201711:42Alliance NewsAlliance NewsAmphion Innovations Sells 4.4 Million Shares In Motif Bio In Loan Deal (ALLISS)LSE:MTFBMotif Bio Plc
15/09/201715:21Alliance NewsAlliance NewsMotif Bio's Iclaprim Gets Orphan Drug Status For Lung InfectionsLSE:MTFBMotif Bio Plc
15/09/201715:07UK RegulatoryMotif Bio PLC iclaprim granted Orphan Drug Designation by US FDALSE:MTFBMotif Bio Plc
08/09/201714:00RNS Non-RegulatoryMotif Bio PLC Host Investor and Analyst Event on September 20LSE:MTFBMotif Bio Plc
31/08/201714:00RNS Non-RegulatoryMotif Bio PLC Company to present at conferences in SeptemberLSE:MTFBMotif Bio Plc
09/08/201712:12Alliance NewsAlliance NewsMotif Bio Completes Treatment Phase Of Second Phase III Iclaprim TrialLSE:MTFBMotif Bio Plc
09/08/201708:00UK RegulatoryMotif Bio PLC REVIVE 2 Trial Last Patient TreatedLSE:MTFBMotif Bio Plc
18/07/201713:38Alliance NewsAlliance NewsMotif Bio Increases Consultancy Fee For Amphion Innovations EmployeeLSE:MTFBMotif Bio Plc
18/07/201708:00UK RegulatoryMotif Bio PLC Amendment to Amphion Consultancy AgreementLSE:MTFBMotif Bio Plc
06/07/201708:00RNS Non-RegulatoryMotif Bio PLC PRESENTING THREE POSTERS ON ICLAPRIM AT ID WEEKLSE:MTFBMotif Bio Plc
28/06/201713:41UK RegulatoryMotif Bio PLC Exercise of warrantsLSE:MTFBMotif Bio Plc
22/06/201716:20UK RegulatoryMotif Bio PLC Result of General MeetingLSE:MTFBMotif Bio Plc
22/06/201708:00RNS Non-RegulatoryMotif Bio PLC Presents at ID Week 2017LSE:MTFBMotif Bio Plc
15/06/201718:42UK RegulatoryMotif Bio PLC Results of Annual General MeetingLSE:MTFBMotif Bio Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network